Notify me when 28 Consultants Ltd files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| GDTC | CytoMed Therapeutics Ltd | Ordinary Shares, no par value | 7.6% | $2,095,145 | 880,313 | 28 Consultants Ltd | 17 Feb 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|